Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted May 2, 2015
Drug Found in Two Weight Loss Supplements
Each was identified during an examination of international mail shipments:
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)
See Related Warnings:
For more warnings and recalls, use the link below.